These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26937669)

  • 1. ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004-2014.
    Cairns R; Daniels B; Wood DA; Brett J
    Med J Aust; 2016 Mar; 204(4):154. PubMed ID: 26937669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric ADHD Medication Exposures Reported to US Poison Control Centers.
    King SA; Casavant MJ; Spiller HA; Hodges NL; Chounthirath T; Smith GA
    Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29784754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clenbuterol toxicity: a NSW poisons information centre experience.
    Brett J; Dawson AH; Brown JA
    Med J Aust; 2014 Mar; 200(4):219-21. PubMed ID: 24580525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings.
    Cairns R; Schaffer AL; Ryan N; Pearson SA; Buckley NA
    Addiction; 2019 Jun; 114(6):1026-1034. PubMed ID: 30098227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Baclofen Overdoses in Australia: Calls to a Poisons Information Centre and a Case Series.
    Jamshidi N; Morley KC; Cairns R; Dawson A; Haber PS
    Alcohol Alcohol; 2019 Jan; 54(1):73-78. PubMed ID: 30508169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
    Wilens TE; Adler LA; Adams J; Sgambati S; Rotrosen J; Sawtelle R; Utzinger L; Fusillo S
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):21-31. PubMed ID: 18174822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poisonings with ADHD medication in children under the age of 5 years in Australia: a retrospective study, 2004-2019.
    Arbaeen A; Wheate NJ; Cairns R
    BMJ Paediatr Open; 2022 Mar; 6(1):. PubMed ID: 36053645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.
    Spiller HA; Hays HL; Aleguas A
    CNS Drugs; 2013 Jul; 27(7):531-43. PubMed ID: 23757186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications.
    Setlik J; Bond GR; Ho M
    Pediatrics; 2009 Sep; 124(3):875-80. PubMed ID: 19706567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate misuse in adult patients and the impact of therapeutic use.
    Jensen LS; Pagsberg AK; Dalhoff K
    Hum Exp Toxicol; 2015 May; 34(5):460-7. PubMed ID: 25062974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADHD and psychostimulants - overdiagnosis and overprescription.
    Dunlop AJ; Newman LK
    Med J Aust; 2016 Mar; 204(4):139. PubMed ID: 26937659
    [No Abstract]   [Full Text] [Related]  

  • 14. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in abuse potential of ADHD drugs measured by contrasting poison centre and therapeutic use data.
    Jensen LS; Pagsberg AK; Dalhoff KP
    Clin Toxicol (Phila); 2015 May; 53(4):210-4. PubMed ID: 25738696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots.
    Poulin C
    Addiction; 2007 May; 102(5):740-51. PubMed ID: 17506151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misuse of Methylphenidate.
    Clemow DB
    Curr Top Behav Neurosci; 2017; 34():99-124. PubMed ID: 26695166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human exposures to veterinary pharmaceutical products reported to Australia's largest poison information centre.
    Wylie CE; Cairns R; Brown JA; Buckley NA
    Clin Toxicol (Phila); 2019 Oct; 57(10):855-866. PubMed ID: 30789080
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
    Cortese S; Adamo N; Del Giovane C; Mohr-Jensen C; Hayes AJ; Carucci S; Atkinson LZ; Tessari L; Banaschewski T; Coghill D; Hollis C; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A
    Lancet Psychiatry; 2018 Sep; 5(9):727-738. PubMed ID: 30097390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.